FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

14801711000001104: Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
51932501000001117 Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
79874101000001119 Sustanon 250mg/1ml solution for injection ampoules (Aspen Pharma Trading Ltd) 1 ampoule en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 4 (CD Anab) true Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Is a Generic Sustanon 250mg/1ml solution for injection ampoules 1 ampoule true Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Is pack of Sustanon 250 injection 1ml ampoules (Organon Laboratories Ltd) false Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Has active ingredient Testosterone propionate false Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Has active ingredient Testosterone isocaproate false Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Has active ingredient Testosterone decanoate false Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Has active ingredient Testosterone phenylpropionate false Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Has excipient Benzyl alcohol false Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Has excipient Arachis oil false Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Has AMP Sustanon 250 injection 1ml ampoules (Organon Laboratories Ltd) true Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Has specific active ingredient Testosterone phenylpropionate false Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Has specific active ingredient Testosterone propionate true Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Has specific active ingredient Testosterone isocaproate true Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Has specific active ingredient Testosterone decanoate true Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Sustanon 250mg/1ml solution for injection ampoules (Organon Laboratories Ltd) 1 ampoule Has specific active ingredient Testosterone 17 phenylpropionate true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start